These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
469 related items for PubMed ID: 6309441
21. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies. Henle W, Henle G. Laryngoscope; 1977 Apr; 87(4 Pt 1):467-73. PubMed ID: 190497 [Abstract] [Full Text] [Related]
22. The immunological approach to study of possibly virus-induced human malignancies using the Epstein-Barr virus as example. Henle W, Henle G. Prog Exp Tumor Res; 1978 Apr; 21():19-48. PubMed ID: 205906 [No Abstract] [Full Text] [Related]
23. [Present status of infectious mononucleosis and Epstein Barr virus]. Ducroix JP, Smail A, Vovan AT, Devauchelle B, Baillet J. LARC Med; 1984 Mar; 4(3):161-3. PubMed ID: 6325836 [No Abstract] [Full Text] [Related]
25. [Epstein-Barr virus as an etiological factor in infectious mononucleosis and other diseases]. Kacprzak-Bergman I, Rudkowski Z. Pediatr Pol; 1977 Nov; 52(11):1293-7. PubMed ID: 201912 [No Abstract] [Full Text] [Related]
27. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Pearson G, Dewey F, Klein G, Henle G, Henle W. J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425 [Abstract] [Full Text] [Related]
29. The sero-epidemiology of Epstein-Barr virus. Henle W, Henle G. Adv Pathobiol; 1976 Nov; (5):5-17. PubMed ID: 220858 [No Abstract] [Full Text] [Related]
30. Cross-neutralization of infectious mononucleosis and Burkitt lymphoma strains of Epstein-Barr virus with hyperimmune rabbit antisera. Coope D, Heston L, Brandsma J, Miller G. J Immunol; 1979 Jul; 123(1):232-8. PubMed ID: 221591 [No Abstract] [Full Text] [Related]
31. The epidemiology of Burkitt's lymphoma: evidence for a causal association with Epstein-Barr virus. De-Thé G. Epidemiol Rev; 1979 Jul; 1():32-54. PubMed ID: 232877 [No Abstract] [Full Text] [Related]
32. Implications of a vaccine for the prevention of Epstein-Barr virus infection: ethical and logistic considerations. Epstein MA. Cancer Res; 1976 Feb; 36(2 pt 2):711-4. PubMed ID: 175931 [Abstract] [Full Text] [Related]
33. [Epstein-Barr virus infections--clinical characteristics and diagnosis]. Ernberg I, Andersson J, Linde A. Lakartidningen; 1989 Oct 25; 86(43):3656-61. PubMed ID: 2554079 [No Abstract] [Full Text] [Related]
34. Serum IgA antibodies of Epstein-Barr virus (EBV)-related antigens. A new feature of nasopharyngeal carcinoma. Henle G, Henle W. Bibl Haematol; 1975 Oct 25; (43):322-5. PubMed ID: 183692 [No Abstract] [Full Text] [Related]
35. [Immunology of Epstein-Barr virus in lymphoproliferative diseases]. Bachmann AE, Giraudo Conesa LC, Braun M. Medicina (B Aires); 1974 Mar 25; 34(2):157-66. PubMed ID: 4368156 [No Abstract] [Full Text] [Related]
36. Issues related to development of Epstein-Barr virus vaccines. Spring SB, Hascall G, Gruber J. J Natl Cancer Inst; 1996 Oct 16; 88(20):1436-41. PubMed ID: 8841018 [No Abstract] [Full Text] [Related]